Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey
Related Posts
Ahmed M, Abbas F, Khan S, Qureshi S, Khan GT, Shafiq SB, Imran W, Waqas SA, Fudim M, Fonarow GC, Greene SJ, Khan MS. Trends[...]
Xu H, Grory BCM, Ikeaba U, Alhanti B, Fonarow GC, Schwamm LH, Smith EE, Messe SR, Ostbye T, De Lemos JA, Peterson ED, Xian Y.[...]
Luchsinger JA, Pan Q, Knowler WC, Munshi M, Watson K, Gadde KM, Schlögl M, Carmichael OT. Public Health. Alzheimers Dement. 2025 Dec;21 Suppl 6(Suppl 6):e098699.[...]